DOCSLIB.ORG

2009-2010 Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2009-2010 Annual Report WORKING TOGETHER TO ADVANCE GENOMICS IN CANADA Abdallah Daar Peter Singer Aled Edwards Program Andrew Emili Andrew Macpherson Ontario Genomics Platform Affiliates Abdallah Daar Peter Singer Anthony Pawson Arturas Petronis Basil Arif Brenda Andrews Aled Edwards Andrew Emili Program Genomics Teaching Prize Summer Brent Zanke Cheryl Arrowsmith Chris Hogue Christian Burks Andrew Macpherson Anthony Pawson Research Fellowship Program Student Network Club Arturas Petronis Basil Arif Brenda Genome Pre-commercialization Business Development Fund Cynthia Guidos Daniel Figeys David MacLennan Gary Bader Geee! In Genome Tak Mak Canadian Barcode of Life Network Andrews Brent Zanke Cheryl Arrowsmith Quaid Morris Gilles Lajoie Jack Greenblatt James Woodgett Chris Hogue Christian Burks Cynthia Ontario Genomics Institute Annual Report 2010 Janet Rossant Jayne Danska Jeff Wrana John Coleman John Dick Guidos Daniel Figeys David MacLennan Celebrating 10 years of genomics leadership Gary Bader Quaid Morris Gilles Lajoie Katherine Siminovitch Kevin Kain Lap-Chee Tsui Lori Frappier Mark Jack Greenblatt James Woodgett Janet University of Guelph Genome Project The Hospital for Sick Children, Toronto Henkelman Mehrdad Hajibabaei Michael Rudnicki Paul Hebert Paul Rossant Jayne Danska Jeff Wrana John The Centre for Applied Genomics (TCAG) The Dynactome: Mapping Piunno Peter Durie Peter Liu Robert Hegele Scott Tanner Shana Kelley Coleman John Dick Katherine Siminovitch Spatio-Temporal Dynamic Systems in Humans Samuel Kevin Kain Lap-Chee Tsui Lori Frappier Lunenfeld Research Institute, Genomic Resource Core Facility Shawn Li Stephen Scherer Ted Sargent Tom Hudson Turlough Finan Ulrich Krull Mark Henkelman Mehrdad Hajibabaei Mount Sinai Hospital, Toronto U n i v e r s i t y o f W e s t e r n Xavier Estivill Database of Genomic Variants Barcode of Life Data Systems (BOLD) M i c h a e l Rudnicki Paul Hebert Paul Ontario, London Genome- Environment Interactions in Autism Chromosome Rearrangement Database Chromosome 7 Annotation Project Piunno Peter Durie Peter Liu Robert Type I Diabetes McMaster University Identification of Hegele Scott Tanner Shana Genetic Pathways that Regulate the Survival and Cystic Fibrosis Mutation Database Human Genome Segmental Duplication Database Kelley Shawn Li Stephen Development of Cancer and Cancer Stem Cells Non-Human Segmental Duplication Database StemBasse Structural Genomics Consortium Integrative Biology University of Toronto Quantum Dot Scherer Ted Sargent Tom Materials and Methods Toronto Yeast Interaction Database Toronto Yeast Pathway Database Hudson Turlough Finan Ulrich Diagnostics: Simultaneous Genomic and Proteomic Krull Xavier Estivill Database Profiling of Multiple Pathogens at Point-of-Care University DNA Barcoding Cancer stem cells Copy Number Varients (CNV) DVS Sciences Protein of Genomic Variants Barcode Health Network FIO Systems Corporation The Contribution Interaction Pathways Genomics and global health The Centre for Applied Genomics (TCAG) of Genetic Modulators of Disease Severity in Cystic of Life Data Systems (BOLD) Dynactome DyNeMo Yeast genetics Pre-commercialization Business Development Fund Chromosome Rearrangement Fibrosis to Other Diseases with Similarities of Clinical Database Chromosome 7 Phenotype Strengthening the Role of Genomics and Genomics Capacity Building Workshops Technology Days Science with Industry Workshops Annotation Project Cystic Global Health Structural and Functional Annotation of the Genomics Technology Seeding Program Ontario Genomics Platform Affiliates Program Human Genome for Disease Study Robarts Research Fibrosis Mutation Database Genomics Teaching Prize Summer Research Fellowship Program Student Network Human Genome Segmental Institute International Barcode of Life (iBOL) Duplication Database Non- Structural Genomics Consortium (SGC) – Phase II Club Genome Geee! In Genome Tak Mak Canadian Barcode Human Segmental Duplication International Regulome Consortium (IRC) Ottawa of Life Network University of Guelph Database StemBasse Structural Health Research Institute Automated Three-dimensional Hospital for Sick Children, Toronto Genomics Consortium Materials Phenotyping of Mouse Embryos Environmental and Methods Toronto Yeast Barcoding through Massively Parallelized Sequencing The Dynactome: Mapping Spatio- Interaction Database Toronto Massively Multiparametric Flow Cytometer Analyzer Temporal Dynamic Systems in Humans Yeast Pathway Database Multiplexed MicroRNA Detection on an Electronic Chip Proteomic Samuel Lunenfeld Research Institute DNA Barcoding Cancer stem Technologies for the Study of Rare Cells University of Ottawa cells Copy Number Varients Software Tools to Simplify Gene Function Prediction Technologies Mount Sinai Hospital,Toronto (CNV) DVS Sciences Protein for Methylome Studies Centre for Addiction and Mental Health University of Western Ontario, London Interaction Pathways Autism Bioproducts and Enzymes from Environmental Metagenomes (BEEM) Genome-Environment Interactions in Genomics and global health The Geosyntec Consultants Genomics for Crop Improvement: Agricultural Pest Type I Diabetes McMaster University Centre for Applied Genomics Management Development of Highly Active Anti-Leukemia Stem Cell (TCAG) Dynactome DyNeMo Therapy (HALT) Therapeutic Opportunities to Target Tumor Initiating Identification of Genetic Pathways Yeast genetics Genomics Cells in Solid Tumors Canadian Program on Genomics and Global that Regulate the Survival and Capacity Building Workshops Health Genetic Determinants of Human Health and Disease Development of Technology Days Science Annotation of Chromosome 7 Proteomics Technology with Industry Workshops Core Facility (PTCF) Genetic Determinants of Cancer and Cancer Genomics Technology Seeding Human Health and Disease Stem Cells Integrative Biology Quantum Dot Diagnostics PARTIAL GENE SEQUENCES DERIVED FROM: Page 7 Butterfly - Danaus plexippus pgm Gene OGI’S MISSION Page 9 Yeast - Saccharomyces cerevisiae strain S288C ARP4 gene Page 11 Cancer Stem Cell - Homo sapiens T-cell acute lymphocytic leukemia 1 (TAL1), USE WORLD-CLASS RESEARCH TO CREATE STRATEGIC GENOMICS RESOURCES Page 13 Genomics platform - TCAG: from the cystic fibrosis mutation database Page 15 Autism - Homo sapiens SHANK3 and multiple ankyrin repeat domains MaRS Centre, Heritage Building t. +1 416-977-9582 AND ACCELERATE ONTARIO’S DEVELOPMENT OF A GLOBALLY-COMPETITIVE Page 17 Mosquito - Anopheles gambiae AGAP007345-PA 101 College Street, Suite HL50 f. +1 416-977-8342 Toronto, Ontario www.OntarioGenomics.ca Page 19 Protein Interaction Mapping - Homo sapiens breast cancer 2, early onset (BRCA2) Canada M5G 1L7 [email protected] LIFE SCIENCES SECTOR. Page 21 Global Health - from HIV-1 isolate SE6954 from Uganda Page 23 Crop pest - Tribolium confusum β tubulin WORKING TOGETHER TO ADVANCE GENOMICS IN CANADA Abdallah Daar Peter Singer Aled Edwards Program Andrew Emili Andrew Macpherson Ontario Genomics Platform Affiliates Abdallah Daar Peter Singer Anthony Pawson Arturas Petronis Basil Arif Brenda Andrews Aled Edwards Andrew Emili Program Genomics Teaching Prize Summer Brent Zanke Cheryl Arrowsmith Chris Hogue Christian Burks Andrew Macpherson Anthony Pawson Research Fellowship Program Student Network Club Arturas Petronis Basil Arif Brenda Genome Pre-commercialization Business Development Fund Cynthia Guidos Daniel Figeys David MacLennan Gary Bader Geee! In Genome Tak Mak Canadian Barcode of Life Network Andrews Brent Zanke Cheryl Arrowsmith Quaid Morris Gilles Lajoie Jack Greenblatt James Woodgett Chris Hogue Christian Burks Cynthia Ontario Genomics Institute Annual Report 2010 Janet Rossant Jayne Danska Jeff Wrana John Coleman John Dick Guidos Daniel Figeys David MacLennan Celebrating 10 years of genomics leadership Gary Bader Quaid Morris Gilles Lajoie Katherine Siminovitch Kevin Kain Lap-Chee Tsui Lori Frappier Mark Jack Greenblatt James Woodgett Janet University of Guelph Genome Project The Hospital for Sick Children, Toronto Henkelman Mehrdad Hajibabaei Michael Rudnicki Paul Hebert Paul Rossant Jayne Danska Jeff Wrana John The Centre for Applied Genomics (TCAG) The Dynactome: Mapping Piunno Peter Durie Peter Liu Robert Hegele Scott Tanner Shana Kelley Coleman John Dick Katherine Siminovitch Spatio-Temporal Dynamic Systems in Humans Samuel Kevin Kain Lap-Chee Tsui Lori Frappier Lunenfeld Research Institute, Genomic Resource Core Facility Shawn Li Stephen Scherer Ted Sargent Tom Hudson Turlough Finan Ulrich Krull Mark Henkelman Mehrdad Hajibabaei Mount Sinai Hospital, Toronto U n i v e r s i t y o f W e s t e r n Xavier Estivill Database of Genomic Variants Barcode of Life Data Systems (BOLD) M i c h a e l Rudnicki Paul Hebert Paul Ontario, London Genome- Environment Interactions in Autism Chromosome Rearrangement Database Chromosome 7 Annotation Project Piunno Peter Durie Peter Liu Robert Type I Diabetes McMaster University Identification of Hegele Scott Tanner Shana Genetic Pathways that Regulate the Survival and Cystic Fibrosis Mutation Database Human Genome Segmental Duplication Database Kelley Shawn Li Stephen Development of Cancer and Cancer Stem Cells Non-Human Segmental Duplication Database StemBasse Structural Genomics Consortium Integrative Biology University of Toronto Quantum Dot Scherer Ted Sargent Tom Materials and Methods Toronto Yeast Interaction Database Toronto Yeast Pathway Database Hudson Turlough Finan Ulrich Diagnostics: Simultaneous Genomic and Proteomic Krull Xavier Estivill Database Profiling of Multiple Pathogens at Point-of-Care University
Load more

Recommended publications
  • The Early History of Medical Genetics in Canada William Leeming OCAD University [email protected]
    OCAD University Open Research Repository Faculty of Liberal Arts & Sciences and School of Interdisciplinary Studies 2004 The Early History of Medical Genetics in Canada William Leeming OCAD University [email protected] © Oxford University Press. This is the author's version of the work. It is posted here for your personal use. Not for redistribution. Original source at DOI: 10.1093/shm/17.3.481. Recommended citation: Leeming, W. “The Early History of Medical Genetics in Canada.” Social History of Medicine 17.3 (2004): 481–500. Web. Leeming, W. (2004). The early history of medical genetics in Canada. Social History of Medicine, 17(3), 481-500. Pre-Publication Draft The Early History of Medical Genetics in Canada Abstract: This article shows that the intellectual and specialist movements that supported the growth of medical genetics in Canada between 1947 and 1990 were emergent phenomena, created, split, and reattached to different groups of actors, and reconfigured numerous times over the course of four decades. In each instance, new kinds of working relationships appeared; sets of diverse actors in local university- hospital settings coalesced into a new collectivity; and, as a collectivity, actors defined and/or redefined occupational roles and work rules. In its beginnings, medical genetics appears to be the object of a serious institutional manoeuver: a movement in support of the creation of examining and teaching positions in human genetics in North American medical schools. With time, the institutionalization of ‘medical genetics’ took hold, spurred on by changes in the rate and direction of service delivery associated with genetic consultation and laboratory services in clinical settings.
    [Show full text]
  • C:\Users\Carolanne\Documents
    If you are having trouble viewing this email, please select here. January 25, 2012 Vol. 20, No. 10 From Banting and Best's discovery of insulin, to Till and McCullough's stem cell breakthrough, the University of Toronto Faculty of Medicine has an incredible legacy of visionary, ground-breaking research. Medical advances traced back to our labs have made countless real-world improvements in patient therapies and care. Together with our TAHSN partners, we truly are a national and international research powerhouse. Ranked 4th for research in Clinical Medicine among World Universities by the Higher Education Council of Taiwan, we are home to 125 Canada Research Chairs, 2 Canada Excellence in Research Chairs, and over 2000 masters and doctoral students who are critical to our research capacity. On January 24, our medical students presented 170 research posters and several oral presentations at their annual research day - a remarkable demonstration of the interest and engagement of our students in scientific enquiry. With the fundamentals in place, there is a tremendous opportunity in Canada to lead the future development of the health research agenda worldwide. But it is not sufficient to do what we have always done. Leadership in the health research of tomorrow will require us to adapt to new realities - where leading-edge investigation takes place across systems and disciplines, and where data can be collected and shared in ways we have not previously envisioned and on a scale we have never before seen. We must create new structures that break down old silos and allow the broad sharing of knowledge.
    [Show full text]
  • 1976-77-Annual-Report.Pdf
    TheCanada Council Members Michelle Tisseyre Elizabeth Yeigh Gertrude Laing John James MacDonaId Audrey Thomas Mavor Moore (Chairman) (resigned March 21, (until September 1976) (Member of the Michel Bélanger 1977) Gilles Tremblay Council) (Vice-Chairman) Eric McLean Anna Wyman Robert Rivard Nini Baird Mavor Moore (until September 1976) (Member of the David Owen Carrigan Roland Parenteau Rudy Wiebe Council) (from May 26,1977) Paul B. Park John Wood Dorothy Corrigan John C. Parkin Advisory Academic Pane1 Guita Falardeau Christopher Pratt Milan V. Dimic Claude Lévesque John W. Grace Robert Rivard (Chairman) Robert Law McDougall Marjorie Johnston Thomas Symons Richard Salisbury Romain Paquette Douglas T. Kenny Norman Ward (Vice-Chairman) James Russell Eva Kushner Ronald J. Burke Laurent Santerre Investment Committee Jean Burnet Edward F. Sheffield Frank E. Case Allan Hockin William H. R. Charles Mary J. Wright (Chairman) Gertrude Laing J. C. Courtney Douglas T. Kenny Michel Bélanger Raymond Primeau Louise Dechêne (Member of the Gérard Dion Council) Advisory Arts Pane1 Harry C. Eastman Eva Kushner Robert Creech John Hirsch John E. Flint (Member of the (Chairman) (until September 1976) Jack Graham Council) Albert Millaire Gary Karr Renée Legris (Vice-Chairman) Jean-Pierre Lefebvre Executive Committee for the Bruno Bobak Jacqueline Lemieux- Canadian Commission for Unesco (until September 1976) Lope2 John Boyle Phyllis Mailing L. H. Cragg Napoléon LeBlanc Jacques Brault Ray Michal (Chairman) Paul B. Park Roch Carrier John Neville Vianney Décarie Lucien Perras Joe Fafard Michael Ondaatje (Vice-Chairman) John Roberts Bruce Ferguson P. K. Page Jacques Asselin Céline Saint-Pierre Suzanne Garceau Richard Rutherford Paul Bélanger Charles Lussier (until August 1976) Michael Snow Bert E.
    [Show full text]
  • Killam Prizes | Prix Killam
    Killam Prizes | Prix Killam Year | Winners | University | Discipline Année Gagnants Université 2021 Michel Bouvier Université de Montréal Health Sciences | sciences de la santé Stephen R. Gill York University Social Sciences | sciences sociales Gilbert Laporte HEC Montréal Engineering | génie Arthur Ripstein University of Toronto Humanities | sciences humaines Douglas Stephan University of Toronto Natural Sciences | sciences de la nature 2020 Cecilia Benoit University of Victoria Social Sciences | sciences sociales Sarah Carter University of Alberta Humanities | sciences humaines Alan Evans Montreal Neurological Institute Health Sciences | sciences de la santé Ted Sargent University of Toronto Engineering | génie Barbara Sherwood Lollar University of Toronto Natural Sciences | sciences de la nature 2019 Yoshua Bengio Université de Montréal Natural Sciences | sciences de la nature André Blais Université de Montréal Social Sciences | sciences sociales Keith W. Hipel University of Waterloo Engineering | génie Stephen W. Scherer University of Toronto Health Sciences | sciences de la santé Lynne Viola University of Toronto Humanities | sciences humaines 2018 André Gaudreault Université de Montréal Humanities | sciences humaines Vladimir Hachinski Western University Health Sciences | sciences de la santé Walter Herzog University of Calgary Engineering | génie James Pinfold University of Alberta Natural Sciences | sciences de la nature Janet Werker University of British Columbia Social Sciences | sciences sociales Canada Council for the Arts
    [Show full text]
  • Phosphoproteomic Characterization of Glycogen Synthase Kinase-3
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2016 Phosphoproteomic Characterization Of Glycogen Synthase Kinase-3 Mansi Shinde University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Cell Biology Commons, Developmental Biology Commons, and the Pharmacology Commons Recommended Citation Shinde, Mansi, "Phosphoproteomic Characterization Of Glycogen Synthase Kinase-3" (2016). Publicly Accessible Penn Dissertations. 2583. https://repository.upenn.edu/edissertations/2583 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2583 For more information, please contact [email protected]. Phosphoproteomic Characterization Of Glycogen Synthase Kinase-3 Abstract Glycogen Synthase Kinase-3 (GSK-3) is a constitutively active, ubiquitously expressed kinase that acts as a critical regulator of many signaling pathways. These pathways, when dysregulated, have been implicated in many human diseases, including bipolar disorder (BD), cancer, and diabetes. Over 100 putative GSK-3 substrates have been reported, based on direct kinase assays or genetic and pharmacological manipulation of GSK-3, in diverse cell types. Many more have been predicted based upon on the prevalence of the GSK-3 consensus sequence. As a result, there remains an unclear picture of the complete GSK-3 phosphoproteome. We have therefore used a large-scale mass spectrometry approach to analyze global changes in phosphorylation and describe the repertoire of GSK-3 substrates in a single cell type. For our studies, we used stable isotope labeling of amino acids in culture (SILAC) to compare the phosphoproteome of wild-type mouse embryonic stem cells (ESCs) to ESCs completely lacking Gsk3a and Gsk3b expression (Gsk3 DKO).
    [Show full text]
  • Gsk3β Mediates Muscle Pathology in Myotonic Dystrophy
    GSK3β mediates muscle pathology in myotonic dystrophy Karlie Jones, … , Nikolai A. Timchenko, Lubov T. Timchenko J Clin Invest. 2012;122(12):4461-4472. https://doi.org/10.1172/JCI64081. Research Article Muscle biology Myotonic dystrophy type 1 (DM1) is a complex neuromuscular disease characterized by skeletal muscle wasting, weakness, and myotonia. DM1 is caused by the accumulation of CUG repeats, which alter the biological activities of RNA-binding proteins, including CUG-binding protein 1 (CUGBP1). CUGBP1 is an important skeletal muscle translational regulator that is activated by cyclin D3–dependent kinase 4 (CDK4). Here we show that mutant CUG repeats suppress Cdk4 signaling by increasing the stability and activity of glycogen synthase kinase 3β (GSK3β). Using a mouse model of DM1 (HSALR), we found that CUG repeats in the 3′ untranslated region (UTR) of human skeletal actin increase active GSK3β in skeletal muscle of mice, prior to the development of skeletal muscle weakness. Inhibition of GSK3β in both DM1 cell culture and mouse models corrected cyclin D3 levels and reduced muscle weakness and myotonia in DM1 mice. Our data predict that compounds normalizing GSK3β activity might be beneficial for improvement of muscle function in patients with DM1. Find the latest version: https://jci.me/64081/pdf Research article GSK3β mediates muscle pathology in myotonic dystrophy Karlie Jones,1 Christina Wei,1 Polina Iakova,2 Enrico Bugiardini,3 Christiane Schneider-Gold,4 Giovanni Meola,3 James Woodgett,5 James Killian,6 Nikolai A. Timchenko,2 and Lubov T. Timchenko1 1Department of Molecular Physiology and Biophysics and 2Department of Pathology and Immunology and Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA.
    [Show full text]
  • By the Numbers Excellence, Innovation, Leadership: Research at the University of Toronto a Powerful Partnership
    BY THE NUMBERS EXCELLENCE, INNOVATION, LEADERSHIP: RESEARCH AT THE UNIVERSITY OF TORONTO A POWERFUL PARTNERSHIP The combination of U of T and the 10 partner hospitals affiliated with the university creates one of the world’s largest and most innovative health research forces. More than 1,900 researchers and over 4,000 graduate students and postdoctoral fellows pursue the next vital steps in every area of health research imaginable. UNIVERSITY OF TORONTO Sunnybrook Health St. Michaelʼs Sciences Centre Hospital Womenʼs College Bloorview Kids Hospital Rehab A POWERFUL PARTNERSHIP Baycrest Mount Sinai Hospital The Hospital University Health for Sick Children Network* Centre for Toronto Addiction and Rehabilitation Mental Health Institute *Composed of Toronto General, Toronto Western and Princess Margaret Hospitals 1 UNIVERSITY OF TORONTO FACULTY EXCELLENCE U of T researchers consistently win more prestigious awards than any other Canadian university. See the end of this booklet for a detailed list of awards and honours received by our faculty in the last three years. Faculty Honours (1980-2009) University of Toronto compared to awards held at other Canadian universities International American Academy of Arts & Sciences* Gairdner International Award Guggenheim Fellows National Academies** Royal Society Fellows Sloan Research Fellows American Association for the Advancement of Science* ISI Highly-Cited Researchers*** 0 20 40 60 801 00 Percentage National Steacie Prize Molson Prize Federal Granting Councilsʼ Highest Awards**** Killam Prize Steacie
    [Show full text]
  • Review of the Faculty of Medicine
    Review of the Faculty of Medicine University of Toronto 2010 Dr. Alastair Buchan, Professor of Stroke Medicine and Head of the Medical Sciences Division, University of Oxford; Dr. Richard Levin, Vice President Health Affairs and Dean of the Faculty of Medicine, McGill; Dr. Joseph B. Martin, Professor of Neurobiology and Dean Emeritus of the Harvard Medical School Introduction This review is written at the request of the Provost and follows the study of extensive materials provided by the Faculty and three days of meetings on site in Toronto (see Appendix A). The reviewers are very grateful to Meg Connell for all of her assistance in arranging an extensive schedule which included meetings with many members of the community representing the University, Departmental, Research Institute, Hospital Research Institutes and Hospital CEOs, and the Deanery Team. We are also very grateful to the Provost and her team, particularly Margie Halling. After agreement with the Provost, this report summarizes our major observations and does not respond specifically to the questions posed in the terms of reference. Executive Summary The reviewers were very impressed with the accomplishments of the University of Toronto, and in particular, the Faculty of Medicine and its Dean. The intention of the University of Toronto in going forward to its Bicentennial in 2030, is to be “a leader amongst the world’s best teaching and research universities in its discovery, preservation, and sharing of knowledge through its teaching and research and its commitment to excellence and equality”. Without a doubt the Faculty of Medicine, founded in 1843 and therefore 167 years old this year, is one of the preeminent Faculties of Medicine and as a total entity, one of North America’s and indeed the world’s largest and most prestigious Academic Health Science Centres.
    [Show full text]
  • Printable List of Laureates
    Laureates of the Canadian Medical Hall of Fame A E Maude Abbott MD* (1994) Connie J. Eaves PhD (2019) Albert Aguayo MD(2011) John Evans MD* (2000) Oswald Avery MD (2004) F B Ray Farquharson MD* (1998) Elizabeth Bagshaw MD* (2007) Hon. Sylvia Fedoruk MA* (2009) Sir Frederick Banting MD* (1994) William Feindel MD PhD* (2003) Henry Barnett MD* (1995) B. Brett Finlay PhD (2018) Murray Barr MD* (1998) C. Miller Fisher MD* (1998) Charles Beer PhD* (1997) James FitzGerald MD PhD* (2004) Bernard Belleau PhD* (2000) Claude Fortier MD* (1998) Philip B. Berger MD (2018) Terry Fox* (2012) Michel G. Bergeron MD (2017) Armand Frappier MD* (2012) Alan Bernstein PhD (2015) Clarke Fraser MD PhD* (2012) Charles H. Best MD PhD* (1994) Henry Friesen MD (2001) Norman Bethune MD* (1998) John Bienenstock MD (2011) G Wilfred G. Bigelow MD* (1997) William Gallie MD* (2001) Michael Bliss PhD* (2016) Jacques Genest MD* (1994) Roberta Bondar MD PhD (1998) Gustave Gingras MD* (1998) John Bradley MD* (2001) Phil Gold MD PhD (2010) Henri Breault MD* (1997) Richard G. Goldbloom MD (2017) G. Malcolm Brown PhD* (2000) Jean Gray MD (2020) John Symonds Lyon Browne MD PhD* (1994) Wilfred Grenfell MD* (1997) Alan Burton PhD* (2010) Gordon Guyatt MD (2016) C H G. Brock Chisholm MD (2019) Vladimir Hachinski MD (2018) Harvey Max Chochnov, MD PhD (2020) Antoine Hakim MD PhD (2013) Bruce Chown MD* (1995) Justice Emmett Hall* (2017) Michel Chrétien MD (2017) Judith G. Hall MD (2015) William A. Cochrane MD* (2010) Michael R. Hayden MD PhD (2017) May Cohen MD (2016) Donald O.
    [Show full text]
  • Annual Summary Corporate Plan 2010
    THE GAIRDNER FOUNDATION Annual Summary Corporate Plan 2010 1 TABLE OF CONTENTS PAGE Section I About the Gairdner Foundation 4 Objectives and Achievements to Date 8 Economic Benefits 9 Section II Performance Results for 2009 Activities 10 Detailed 2009 Evaluations 11-14 Planned Activities and Anticipated Results 2010 15 Section III Financial Summary 16 Planned Receipts and Disbursements 2010 18 Section IV Risk Management 19 Section V Performance Monitoring 21 2 "Receiving the Gairdner Award is not only a tremendous honor. It is also an induction into the Gairdner family of exceptional biomedical scientists. The 50th anniversary celebration was a joyous family reunion." Gairdner (1981) and Nobel Laureate, Michael Brown, Southwestern University, Dallas 3 THE GAIRDNER FOUNDATION CORPORATE PLAN EXECUTIVE SUMMARY HISTORY The Gairdner Foundation was created in 1957 by James Arthur Gairdner to recognize and reward the achievements of medical researchers whose work contributes significantly to improving the quality of human life. Since the first awards were made in 1959, the Gairdner Awards have become Canada's foremost international award. The Canada Gairdner International Awards are one of the three most prestigious awards in medical science, along with the Swedish Nobel Prize in Medicine and the American Albert Lasker Medical Research Awards. They hold up the pinnacle of achievement as a mirror to Canadians, and in so doing, play a role in helping Canada achieve its goals of excellence. The Gairdner was incorporated in December 1957 as a charitable corporation under the laws of the Province of Ontario, Canada. Its funds originally derived from the personal gifts of the founder and members of his family.
    [Show full text]
  • 100 Years of Biochemistry at the University of Toronto – Marian A
    Bulletin The Canadian Society of Biochemistry, Molecular & Cellular Biology La Société canadienne de biochemie, de biologie moléculaire et cellulaire ISSN 1197-6578/2007 2007 www.csbmcb.ca Bulletin The Canadian Society of Biochemistry, Molecular & Cellular Biology La Société canadienne de biochemie, de biologie moléculaire et cellulaire 2007 www.csbmcb.ca 2 CSMCB/SCBBMC BULLETIN 2007 FRONT COVER IMAGES: Illustration by Martin Krzywinski, Scientist (Mapping), Canada’s Michael Smith Genome Sciences Centre CSMCB/SCBBMC BULLETIN 2007 3 Contents CSBMCB Board for 2007-2008................................................................................................4 CSBMCB President’s Report...................................................................................................5 Incoming Members of the CSBMCB Executive Board 2006-2007....................................8 Laura Frost, Vice-President; Jean-Pierre Perreault, Councillor; David Williams, Councillor Minutes of the 50th CSBMCB Annual General Meeting ..................................................12 CSBMCB/SCBBMC Financial Statement.............................................................................15 The 50th Annual Meeting of the CSBMCB.........................................................................17 Poster and travel award recipients for the 2007 CSBMCB Meeting .............................19 Scenes from the 2007 CSBMCB Meeting ............................................................................21 Program for the 51st Annual Meeting of the
    [Show full text]
  • NEWSBRIEFS I Five Physicians Chosen for Order of Canada
    NEWSBRIEFS I Five physicians chosen for Order of Canada Canada's highest distinction Dr. Wilson, nominated as one of Dr. Germain Bigue, born in awarded in recognition 17 new officers, was born in Ed- Saint-Thcle, Quebec in 1912, will monton in 1913, and has had a become a member of the Order. of outstanding achievement lifetime involvement with medical Dr. Bigu. has devoted considerable and service. education in this country; from skill and energy to improving the 1968-78 he served as director of health services in the Val d'Or re- "I don't do post-mortems on emo- the R.S. McLaughlin examination gion: he opened a clinic for the tions", commented Dr. Donald and research centre of the Royal workers at the Lamaque and Sigma Wilson of Edmonton, "but I College of Physicians and Surgeons, mines in the 1950s; served as chief couldn't help being pleased and sur- and was instrumental in ensuring of surgical services at St-Sauveur prised when I heard this was in the that all doctors, wherever they had Hospital from 1955-1965 and sub- wind. And humbled - because trained, were tested to the same sequently as director of professional there are so many great Canadians levels of excellence and compe- services from 1970-78; established who don't get on the Governor tence. the first blood bank and a division General's list." Among his several other accom- of the Canadian Cancer Society in Dr. Wilson is one of five physi- plishments, from 1954-68 Dr. Wil- the area; and is active in commu- cians among the 57 Canadians re- son was professor and chairman of nity affairs ranging from the Val cently appointed to the Order of the University of Alberta's depart- d'Or Historical Society to the Val Canada, the highest distinction in ment of medicine, from 1978-80 d'Or senior citizens' home.
    [Show full text]